Tranexamic Acid
(tran'' ex am' ik as' id).
C8H15NO2 157.2 trans-4-(Aminomethyl)cyclohexanecarboxylic acid; Cyclohexanecarboxylic acid, 4-(aminomethyl)-, trans ![]() ![]() ![]() DEFINITION
Tranexamic Acid contains NLT 99.0% and NMT 101.0% of C8H15NO2, calculated on the dried basis.
IDENTIFICATION
ASSAY
• Procedure
Sample solution:
140 mg of Tranexamic Acid in 20 mL of glacial acetic acid
Titrimetric system
(See Titrimetry
![]() ![]()
Mode:
Direct titration
Titrant:
0.1 N perchloric acid VS
Endpoint detection:
Potentiometric
Analysis
Sample:
Sample solution
Titrate with 0.1 N perchloric acid VS, determining the endpoint potentiometrically. Carry out a blank titration.
Each mL of 0.1 N perchloric acid is equivalent to 15.72 mg of C8H15NO2.
Acceptance criteria:
99.0%–101.0% on the dried basis
IMPURITIES
Inorganic Impurities
• Residue on Ignition
![]() ![]()
• Heavy Metals, Method II
![]() ![]()
• Chloride and Sulfate, Chloride
![]() ![]()
Organic Impurities
• Procedure
Mobile phase:
Dissolve 11.0 g of anhydrous monobasic sodium phosphate in 500 mL of water, and add 5 mL of triethylamine, followed by 1.4 g of sodium lauryl sulfate. Adjust with diluted phosphoric acid (10% w/w) to a pH of 2.5, and dilute with water to 600 mL. Mix this solution with 400 mL of methanol.
System suitability solution:
0.2 mg/mL of USP Tranexamic Acid RS and 0.002 mg/mL of USP Tranexamic Acid Related Compound C RS in water
Standard solution:
50 µg/mL of USP Tranexamic Acid RS in water
Sample solution:
10 mg/mL of Tranexamic Acid in water
Chromatographic system
Mode:
LC
Detector:
UV 220 nm
Column:
4.6-mm × 25-cm; 5-µm packing L1
Flow rate:
1 mL/min
Injection size:
20 µL
Run time:
3 times the retention time of tranexamic acid
System suitability
Sample:
System suitability solution
Suitability requirements
Resolution:
NLT 2.0 between tranexamic acid and 0.002 mg/mL of tranexamic acid related compound C
Analysis
Samples:
Standard solution and Sample solution
Calculate the percentage of each individual impurity in the portion of Tranexamic Acid taken:
Result = (rU/rS) × (CS/CU) × (0.1F)
Acceptance criteria
Individual impurities:
See Impurity Table 1.
Total impurities:
NMT 0.2%
[Note—Disregard any peak less than 0.025%. ]
Impurity Table 1
SPECIFIC TESTS
• Loss on Drying
![]() ![]() ![]() ADDITIONAL REQUIREMENTS
• Packaging and Storage:
Preserve in tight containers, and store at a temperature not exceeding 30
![]()
• USP Reference Standards
![]() ![]()
USP Tranexamic Acid Related Compound C RS
(RS)-4-(Aminomethyl)cyclohex-1-enecarbocylic acid. C8H13NO2 155
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
USP35–NF30 Page 4911
Pharmacopeial Forum: Volume No. 34(6) Page 1484
|